Transgenomic, Inc. (NASDAQ:TBIO) [Trend Analysis] moved down reacts as active mover, shares a loss -10.81% to trade at $0.66 and the percentage gap between open changing to regular change was -5.39%.
Transgenomic, Inc. (TBIO) reported that a licensing contract with leading Canadian laboratory services provider LifeLabs, which has selected Transgenomic’s ICE COLD-PCR (ICP) technology as its mutation enrichment platform for cancer testing. The three-year, renewable contract includes a non-exclusive license to the ICP technology in Canada. Separately, Transgenomic also reported issuance of a new Canadian patent for ICP.
“LifeLabs is among the largest laboratory service providers in North America, and we view their adoption of ICE COLD-PCR as a key validation of both the technology and our commercial model that focuses on licensing to a wide variety of molecular diagnostics partners worldwide,” commented Paul Kinnon, President and Chief Executive Officer of Transgenomic.
The firm’s current ratio calculated as 0 for the most recent quarter. The firm past twelve months price to sales ratio was 14.40 and price to cash ratio remained 187.24
Workday, Inc. (NYSE:WDAY) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it -0.09% to close at $82.04 with the total traded volume of 1.22 Million shares. Fundamentalist can give brighter side of a picture but an analyst can glow the darker parts stored in any investment. Let us view how analysts have ranked WDAY in recent few months. In ratings table the WDAY given BUY ratings by 12 analysts in current phase and 2 analysts suggest it as overweight security. The 3 number of analyst/s have SELL recommendation for current month on WDAY. While 23 number of analysts gave ratings for HOLD in current. As per remarks given by WSJ, overall consensus pool recommend it as Hold security.
The stock was assessed in terms of profitability as current quarter EPS estimate trends showed $-0.01 at current month while compared with $-0.01 in a month ago. The stock next year first quarter current estimate trend for EPS was for $0.04 and on annual basis FY 2016 estimate trends at current was for $0.03 as compared to one month ago of $0.03, and for next year per share earnings estimates have $0.28.
The firm has institutional ownership of 90.20%, while insider ownership included 1.30%. Its price to sales ratio ended at 11.22. WDAY attains analyst recommendation of 2.60 with week’s performance of 0.42%.